Absolute risk differences (ARDs) for development of cutaneous T-cell lymphoma after dupilumab use
收藏NIAID Data Ecosystem2026-05-10 收录
官方服务：
资源简介：
Absolute risk differences (ARDs) for development of cutaneous T-cell lymphoma after dupilumab use, ages 18-59 and Absolute risk differences (ARDs) for development of cutaneous T-cell lymphoma after dupilumab use, ages ≥60
18~59岁人群使用度普利尤单抗（dupilumab）后发生皮肤T细胞淋巴瘤（cutaneous T-cell lymphoma）的绝对风险差（absolute risk differences，ARDs），以及≥60岁人群使用度普利尤单抗后发生皮肤T细胞淋巴瘤的绝对风险差（ARDs）
创建时间：
2025-12-29
